Commit To Purchase Verve Therapeutics At $10, Earn 22.4% Annualized Using Options
March 22, 2024 at 11:34 AM EDT
Investors eyeing a purchase of Verve Therapeutics Inc (VERV) shares, but tentative about paying the going market price of $13.11/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $10 strike, which has a bid at the time of this writing of 90 cents..